Your browser is out of date

With an updated browser, you will have a better Medtronic web site experience. Update my browser now.

×

Skip to main content
Play Video This will play a video. - MiniMed 670G

MINIMEDTM 670G INSULIN PUMP SYSTEM

Discover the world's first self-adjusting insulin pump system for people living with type 1 diabetes**
PLAY VIDEO

Believe in better control

NOTHING IS MORE INSPIRING THAN MORE FREEDOM

Sleeping soundly. Waking up energized.

SLEEPING SOUNDLY and waking up energized

The MiniMed™ 670G system can help you wake up in the  morning well-rested and ready to take on the day.

Enjoying meals without interruption.

Enjoying Meals without interruptions

At mealtimes, you simply check your blood glucose levels and enter the number of carbs you intend to eat. Instead of calculating your insulin needs, you can now let your pump do the math.‡

Living life more spontaneously.

Living Life more spontaneously

The MiniMed™ 670G system with SmartGuard Auto Mode gives you freedom to think less about managing your diabetes. It focuses on you, so you can focus more on whatever the day brings.2

Child playing in water on beach

waterproof up to 24 hours

Make a splash. The MiniMed™ 670G pump can stay underwater to a depth of up to 12 feet (3.5 meters) for up to 24 hours. The MiniMed 670G is waterproof at the time of manufacture and when the reservoir and tubing are properly inserted.

key features

 What would your life be like if you knew that your glucose levels were always right where they needed to be? The MiniMed 670G system’s revolutionary technology automatically works to keep your glucose levels in range, day and night.

 

 

INSPIRING CONFIDENCE.

THE WORLD’S FIRST HYBRID CLOSED LOOP SYSTEM.

SMARTGUARD TECHNOLOGY

The MiniMed™ 670G system offers SmartGuard™, the only technology that mimics some of the functions of a healthy pancreas by providing two new levels of automated insulin delivery.

  Watch the video

AUTO MODE*

  • Automatically adjusts||**  your basal (background) insulin every five minutes based on your CGM readings‡.
  • Helps keep your sugar levels in your target range for fewer lows and highs — day and night†‡.

  See how Auto Mode works

SUSPEND BEFORE LOW

  • Stops insulin up to 30 minutes before reaching your preset low limits.
  • Automatically restarts insulin when your levels recover without bothersome alerts.‡
  • Helps you avoid lows and rebound highs.1
MiniMed 670G

   

comparison chart

Insulin Delivery Systems - Technology Comparison

Comparison Chart
Comparison Chart 2
670 Nicky

meet real people like you on the minimedTM 670G system with SmartGuardTM technology

READ MORE
MiniMed 670G System
Woman and baby

My HbA1c dropped from 7.6% to 6.9% in less than 3 months.

MiniMedTM 670G user

My HbA1c dropped from 7,6% to 6,9% in less than 3 months

Image of Adam

LIFE WITH THE MINIMEDTM 670G

Hear from Canadians living with Type 1 diabetes about their experience with the MiniMedTM 670G System. The MiniMed™ 670G is indicated for people living with Type 1 diabetes, seven years of age and older.

WATCH VIDEO

SPECIFICATIONS

     

Expand All

Water Resistance

Waterproof pump, protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.

Sizing

Environmental Conditions

Pump Memory

Compatible Infusion Sets

Guardian Link (3) Transmitter

Bolus Speed Options

Bolus Programming Increments

Altitude Range

Backlight

Basal Delivery Rate Range

Guardian Sensor (3)

CareLink™ USB

One-Press Serter

Battery and Power

Reservoir

CONTOUR NEXT LINK 2.4 WIRELESS BLOOD GLUCOSE MONITORING SYSTEM

REQUEST MORE INFORMATION

By submitting this form you are consenting to and confirm the following:

  • That Medtronic can communicate with you regarding our diabetes products by telephone, fax, mail and/or e-mail.
  • That Medtronic stores information, including personal health information, on systems located outside of Canada.
  • That you have read and are aware of our privacy policy.
  • That you grant Medtronic of Canada permission to send you updates on diabetes and diabetes technology.
  • You may revoke this permission at any time by emailing medtronicdiabetescc@medtronic.com
  • Medtronic respects the confidentiality of personal information. We assure you we will not share your personal information, except as otherwise noted in our privacy policy.

UPGRADE TO THE MINIMED™ 670G SYSTEM TODAY

If you've been considering a change, this could be a great time to make the move to our latest technology. Fill out the form to learn more.

MiniMed 670G System

MINIMEDTM 670G RESOURCES

Find user guides, brochures and other reference materials for the MiniMedTM 670G.

VISIT SUPPORT

MINIMEDTM 670G FAQ

Learn more about how the MiniMedTM 670G works by reading our list of frequently asked questions.

READ FAQ

MEDTRONIC SERVICES

Find diabetes training and education, global assistance, services and more.

SEE SERVICES
*

WARNING: Do not use Auto Mode for a period of time after giving a manual injection of insulin by syringe or pen. Manual injections are not accounted for in Auto Mode. Therefore, Auto Mode could deliver too much insulin. Too much insulin may cause hypoglycemia. Consult with your healthcare professional for how long you need to wait after a manual injection of insulin before you resume Auto Mode.

†

Mean Absolute Relative Difference.

‡

Based on sensor glucose.

§

WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia.

||

** Refers to AutoMode. Some interaction required. Individual results may vary. The MiniMed 670G is indicated for people living with diabetes 7 years of age and older.

1

Bailey T, et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR®NEXT LINK 2.4 Blood Glucose Monitoring System. Poster presented at the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2014 February 5–8, Vienna, Austria.

2

Data on file. MiniMed 670G user experience survey, period Jun 2017 - Jan 2018, n=13.571

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.